Loading insider details...
Beta
Latest Form 4 (Oct 2, 2026): Grant/Award of 1,325 CADL shares, $11.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | Candel Therapeutics, Inc. (CADL) | Grant/Award | 1,325 | $11.5K |
| Jul 1, 2026 | Candel Therapeutics, Inc. (CADL) | Grant/Award | 1,331 | $11.5K |
| Jun 24, 2026 | Candel Therapeutics, Inc. (CADL) | Grant/Award | 32,000 | n/a |
| Jun 12, 2026 | Milestone Pharmaceuticals Inc. (MIST) | Grant/Award | 77,000 | n/a |
| May 1, 2026 | Emergent BioSolutions Inc. (EBS) | Grant/Award | 187,708 | n/a |
| Apr 2, 2026 | Candel Therapeutics, Inc. (CADL) | Grant/Award | 2,795 | $11.5K |
| Mar 6, 2026 | Emergent BioSolutions Inc. (EBS) | Tax Withholding | 37,055 | $312.7K |
| Jul 15, 2025 | Milestone Pharmaceuticals Inc. (MIST) | Grant/Award | 100,000 | n/a |
| Jun 26, 2025 | Candel Therapeutics, Inc. (CADL) | Grant/Award | 64,239 | $300.0K |
| Jun 18, 2025 | Candel Therapeutics, Inc. (CADL) | Grant/Award | 14,240 | n/a |